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ABSTRACT 
 
The indiscriminate use of antibiotics and the emergence of resistant 
microorganisms have become a major challenge for the food industry. The purpose of 
this work was to microencapsulate the bacteriophage UFV-AREG1 in a calcium 
alginate matrix using microfluidic devices and to study the viability and efficiency of 
retention. The microcapsules were added to gel of propylene glycol for use as an 
antimicrobial in the food industry. The technique showed the number of the phage 
encapsulation, yielding drops with an average 100-250 µm of diameter, 82.1 ± 2% 
retention efficiency and stability in the gel matrix for 21 days. The gel added to the 
microencapsulated phage showed efficiency (not detectable on the surface) in 
reducing bacterial contamination on the surface at a similar level to antimicrobial 
chemicals (alcohol 70%). Therefore, it was possible to microencapsulate 
bacteriophages in alginate-Ca and apply the microcapsules in gels for use as 
sanitizers in the food industry. 
 
 
 
1. Introduction 
 
The indiscriminate use of antibiotics and the emergence of 
resistant microorganisms have aroused interest in alternative 
methodologies to control pathogens and spoilage microbes in foods 
and in different areas of the food industry. Among these 
methodologies, the use of bacteriophages, bacteriocins and 
essential oils, which can be widely used in food packaging, stands 
out [1, 2]. 
Recently, many studies have examined the most effective 
processes to reduce or eliminate pathogenic microorganisms that 
appear in commodities of animal origin. These processes include 
the implementation of food safety systems, good agricultural and 
manufacturing practices, consistent and continuous training, and 
multidisciplinary research. Among these pathogens, Salmonella 
spp, Listeria monocytogenes and Escherichia coli O157:H7 are the 
most important. E. coli O157:H7 has been associated with 
outbreaks involving lettuce, spinach, culinary herbs and other fresh 
products [3]. According to Shekarforoush and co-workers [4] E. 
coli is 
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considered an important agent which can spread through direct 
contact and by consumption of contaminated foodstuff, surviving 
to a 15% concentration of acetic, citric and lactic acid. This 
bacterium can cause hemorrhagic colitis, hemolytic uremic 
syndrome (HUS), thrombocytopenic purpura and, occasionally, 
death.  
The use of bacteriophages has become a promising therapy, 
especially due to bacterial resistance to antibiotics, which 
represents an important factor in public health due to the mortality 
caused by multiresistant bacteria. Furthermore, it also decreases 
concerns about antibiotic residues in foods and the compulsory 
retention period by humans [5]. The main applications of 
bacteriophages have been by oral administration of solutions 
containing the phages in therapy, or by spraying foods or 
equipment surfaces for decontamination [6, 7]. Another emergent 
technique is the application of encapsulated bacteriophages. 
Essentially, encapsulation consists of a process in which the 
material to be encapsulated is maintained inside the encapsulating 
material to minimize lesions or losses. These losses can occur 
during passage through the gastrointestinal tract, during industrial 
processes and others, which can minimize the antimicrobial effect 
of bacteriophages. The encapsulation also permits the controlled 
liberation of viral particles under the influence of specific 
conditions [8]. 
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In this context, the methods and equipment of microfluidics 
can be used for the encapsulation of micro and nanostructures in 
polymeric microgels [9, 10]. The system is constituted by channels 
ranging from tens to hundreds of micrometers, with different 
geometries and the most varied materials, such as polymers, glass, 
ceramics, metals, etc. [10, 11]. The manipulation of multiple-phase 
flow in the device allows low polydisperse emulsions to be 
generated, which may be single or double emulsions, of several 
diameters, expanding the fields of application. The higher degree 
of control offered by this method and the completely distinct fluid 
streams make microfluidics a very promising and versatile 
technique [12]. The microfluidic device can be utilized to produce 
microcapsules, microparticles and even nanoparticles, depending 
on the manufacture and design of the equipment [10]. 
Polymers that are purchased from natural sources of 
renewable resources are even more interesting because they have a 
low cost, water solubility, biocompatibility, biodegradability, 
ability to gel and good availability. Sodium alginate is a natural 
nonbranched polysaccharide (extracted from brown seaweed and 
some bacteria) formed by two types of polyuronic acid, β-D-
mannuronic acid (M) and α-L-guluronic acid (G) bound by (1 → 4) 
-glycosidic bonds, of varied composition and sequence. These 
monomers are epimers with different orientations in the polymer 
chain, and the G unit is responsible for allowing cross-ionic 
bonding. The gel is formed by connecting the units of guluronic 
acid with cations, resulting in a three-dimensional network that is 
maintained by ionic interactions [13-16]. 
Sodium alginate is widely used as a gelling agent due to its 
ability to form gels with divalent cations, such as Ca+2, Ba+2 or 
Sr+2. The use of alginate is appropriate for encapsulation owing to 
its GRAS (Generally Recognized As Safe) aspect and absence of 
toxicity [17]. Because of the relatively mild gelling process, Ca-
alginate particles have found numerous applications as 
encapsulation vehicles and delivery systems for cells, proteins, 
enzymes and drugs, as well as useful tools for the controlled 
release of drugs in biomedical science and pharmaceutical 
engineering [18]. 
Based on these premises, the aim of this work was to 
microencapsulate the bacteriophage UFV-AREG1 in a matrix of 
calcium alginate, using microfluidic devices. The microcapsules 
produced by the device were added to a propylene glycol gel for 
application in the sanitization of food surfaces, evaluating the 
antimicrobial effect. To our knowledge, there is no work in the 
literature about the encapsulation of bacteriophages using 
microfluidics for possible applications in the food industry; thus, 
this is an initiative to increase phage stability and viability during 
storage. 
 
2. Material and methods 
 
2.1 Microorganism 
 
The bacterium Escherichia coli O157:H7 (ATCC 43895) was 
acquired from the Fiocruz (Fundação Oswaldo Cruz) collection. 
The bacteriophage UFV-AREG1, isolated from cowshed 
wastewater, showed specificity for enterohemorrhagic E. coli 
O157:H7 (ATCC 43895), E. coli 0111 (CDC 011ab) and E. coli 
(ATCC 23229). The genome sequence of the bacteriophage UFV-
AREG1 is available under the accession number KX009778.3 in 
GenBank [19]. 
 
2.2. Determination of the diameter of viral particles 
 
The dynamic light scattering technique is a method of 
investigation in the macromolecular system, characterized by being 
a noninvasive method and allowing small volumes to be used. 
The technique was used to determine the average 
hydrodynamic radius (HR) and size distribution of viral particles. 
The equipment used was Dynamic Light Scattering (DLS), Static 
Light Scattering (SLS) (Brookhaven Co. - USA) and light 
scattering Zetasizer (Zetasizer Nano S – Malvern – UK). In order 
to obtain homogeneous samples, a filtration was made using 
syringes with a hydrophilic 13 mm cellulose acetate membrane 
(Analitica, USA) with 0.22 μm pore size. All measures were made 
under controlled temperature (25.0 ± 0.5 ºC). The measures of light 
scattering were performed at angles ranging from 30 º to 135 º, at 
intervals of 15 º. The technique is appropriate for determination of 
structures of 10 to 1000 nm. The second-order cumulant model 
was adjusted using the data, from which was obtained the average 
relaxation rate of decay of this correlation ( ̅). The measurement 
was done three times, and the average diameter of particles was 
reported by the linear adjustment of a graph  ̅ versus q², where q 
represents the scattering vector module. The slope obtained by this 
adjustment is self-diffusion coefficient, D, of the structures. The 
hydrodynamic radius was calculated using the Stokes-Einstein 
equation. 
 
2.3. Microfluidic device 
 
The device function was to produce emulsions with low-size 
dispersion from immiscible liquids. 
Two cylindrical capillary tubes were used. The hydrophobic 
treatment was applied with 10% (v/v) solution of 
octadecyltrimethoxysilane in toluene. To mount a cylindrical 
device, one was placed inside the other. The dispersion of liquids 
in the device was controlled by the sheer force to release the drops, 
producing water/oil emulsion (w/o) as shown in Figure 1. The 
connections were made to set the entries of the dispersed and 
continuous liquid phase in the device, which were placed in 
syringes; the region where the emulsion formed is called 
constriction. The syringes were connected to syringe pumps (PHD 
4400 Programmable - Harvard Apparatus, USA), which controlled 
the entry of the liquid. The experiment was monitored by an optical 
microscope, which was connected to an image-capture CMOS 
camera connected to the computer. 
 
2.4. Production of calcium alginate microcapsules 
 
For the calcium alginate matrix, 1.5 % (w/v) of sodium 
alginate (Vetec, Brazil) was added to purified water. The mixture 
was homogenised in a magnetic stirrer until complete dissolution 
of alginate. The phage solution 106 PFU⋅mL–1 (1:10 v/v) was 
added to the mixture. After this procedure, the solution was filtered 
through nylon filters (Analitica, USA) of 0.45 μm within the 
 
 
 
 
Figure 1: Microfluidic device and Alginate-Ca microcapsule production. 
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syringe, and this was the dispersed phase. Sunflower oil with 
SPAN 80 (Sigma-Aldrich, USA) (0.3% w/v) added was also 
filtered, and this was the continuous phase. The syringes were 
coupled to the flow pump and the microfluidic device. Flow rates 
were controlled to verify the formation and detachment of droplets 
in a regular manner, and to determine the desired size of the 
microcapsules. For the dispersed phase 50-100 μL⋅h–1 was used, 
and 1000-1500 μL⋅h–1 for the continuous phase. The droplets 
produced were collected in a CaCl2 solution (Vetec, Brazil) (0.1 
mol⋅L–1) to form the alginate-Ca microcapsules (Figure 1). After a 
few minutes of cation exchange (approximately 20 min), alginate-
Ca microcapsules were obtained. 
After formation of the microcapsules, the excess oil and the 
CaCl2 solution were removed with Pasteur pipette and the 
microcapsules washed with water to remove oil residues. The 
water was withdrawn with the pipette, leaving only the 
microcapsules, which were stored in 1.5 mL microtubes and 
reserved in refrigeration temperature for evaluation of retention 
efficiency and subsequent addition in propylene glycol gel.  
 
2.5. Retention Efficiency (RE) for the Ca-alginate matrix and 
stability of microcapsules in propylene glycol gel 
 
For retention efficiency of the bacteriophages in Ca-alginate 
the titration of microencapsulated bacteriophages was determined. 
The dissolution of the microcapsules for releasing the 
bacteriophage was performed as described by Liu and co-workers 
[20]. The microcapsules were suspended in Broken-Microsphere 
Solution (MBS) containing sodium citrate (Neon, Brazil) 50 
mmol⋅L–1, sodium bicarbonate (Neon, Brazil) 0.2 mol⋅L–1 and Tris-
HCl (Sigma-Aldrich, USA) 50 mmol⋅L–1, pH 7.5 for a few minutes 
until total dissolution of the microcapsules for phage release.The 
bacteriophages released from microcapsules were serially diluted 
using SM buffer (50 mmol∙L–1 Tris-HCl - Sigma-Aldrich, USA 
[pH 7.5], 0.1 mol⋅L–1 NaCl - Vetec, Brazil, 8 mmol⋅L–1 
MgSO4⋅7H2O - Chemco, Brazil, 0.01% gelatin - Merck, USA) to 
obtain from 10 to 100 plaque-forming units (PFU). On a plate 
containing agar BHI base (Brain Heart Infusion - Himedia, India + 
agar 1.2% - Himedia, India) 100 mL of bacterial culture in log 
phase and 100 μL of phage suspension dilution were added to a 
tube containing agar overlay (Brain Heart Infusion broth - 
Himedia, India + agar 0.6% - Himedia, India) and poured on the 
plates. The plates were incubated at 35 ± 2 °C / 18- 24 h. 
The retention efficiency (RE) of bacteriophages in alginate 
microcapsules was determined by equation 1 per Gomes and co-
workers [21], adapted to bacteriophages. 
 
   
                                    
                                   
                   
 
Where "entrapped quantity of bacteriophages" is the concentration 
of bacteriophages present in the microcapsules and the "original 
quantity of bacteriophages" indicates the concentration of 
bacteriophages initially used to make the microcapsules of 
alginate. 
The stability was assessed for 21 days (0, 7, 14 and 21 days). 
To determine the stability of microcapsules added to the propylene 
glycol gel, the titration proceeded as described above. After 
incubation for 18-24 h / 37 °C, the lysis plaques were counted and 
expressed as plate forming units (PFU⋅mL–1).  
 
2.6. Characterization of microcapsules containing 
bacteriophages by confocal microscopy  
 
The characterization was performed to assess the homogeneity 
of phage solution within the microparticles and stability. Before 
encapsulation, the UFV-AREG1 phage was labeled with fluorescein 
isothiocyanate, fluorescence emitted at 488 nm (FITC, Sigma- 
Aldrich, USA). The UFV-AREG1 bacteriophage was labeled with 
isothiocyanate using the procedure described by Bakhshayeshi and 
co-workers with modifications [22]. Briefly, 1.2 ml of phage 
suspension in concentration of 106 PFU⋅mL–1 in 0.1 M borate buffer 
pH 9.2 was mixed with 0.021 g of FITC and 5 mL of N,N-
dimethylmethanamide (also known as dimethylformamide or DMF - 
Sigma-Aldrich, USA). The resulting mixture was left overnight at 4 
°C. Dialysis of the mixture was carried out to remove excess of 
fluorophore. The buffer was changed every four hours.  
Next, the same phage sample was encapsulated per the 
methodology described in Section 2.4 and visualized by confocal 
microscopy (Confocal Microscope - LSM 510 Meta Laser Scanning 
- Zeiss, Germany) at the Núcleo de Microscopia e Microanálise, 
Universidade Federal de Viçosa. Through fluorescence radiation of 
the marked phages the homogeneity of the distribution of the phage 
around the microcapsules was verified.  
 
2.7. Application of Ca-alginate microcapsules in a propylene 
glycol gel and antimicrobial evaluation  
 
The gel was prepared using the following ingredients: 2% (w/v) 
hydroxymethyl cellulose (Mapric, Brazil); 5% (w/v) propylene 
glycol (Mapric, Brazil); 0.1% (w/v) EDTA (Mapric, Brazil); 0.2% 
(w/v) methylparaben (Mapric, Brazil). The volume was completed to 
100% with deionized water. With the water under heating and 
stirring the hydroxymethyl cellulose was sprayed, then propylene 
glycol, EDTA, and methyl paraben were added. The system was 
kept under stirring until a temperature of 70 °C. After reaching that 
temperature, the heat was turned off. Under stirring, the microtube 
(1.5 mL) containing alginate microcapsules with phage, was added 
and mixed in solution. The solution was stored in appropriate 
containers for further use. Alcohol Gel 70% purchased commercially 
was also used as an antimicrobial in comparison to the manufactured 
gel and a control surface containing only bacteria, without the use of 
antimicrobials.  
To evaluate the stability of the microcapsules in the gel, to a 
tube containing 1.0 mL of gel with microcapsules, more phage was 
added to 4.0 mL of MBS solution for total dissolution and release of 
phage. From this stock solution, 1.0 mL was transferred to a tube 
containing 4.0 mL of SM buffer, proceeding to serial dilution. To 
evaluate the antimicrobial efficiency of the gel with microcapsules, 
alcohol gel and surface control, microbiological analyses were 
performed in vitro using E. coli O157:H7. The pre-activated bacteria 
at a concentration of 104 CFU⋅mL–1 were added to a previously 
sterilized laboratory bench area divided into three parts, allowing the 
bacteria to act for 20 minutes, which is the average generation time 
of E. coli. Next, to first part gel with microcapsules was applied, to 
the second part alcohol gel 70%, and to the third nothing was 
applied. The swab technique is considered a standard methodology 
for microbiological analysis by the American Public Health 
Association (APHA).  
The swab technique is used to evaluate surfaces and handlers' 
hands in the food industry. Sterilized swabs were moistened in tubes 
containing 10 mL of 0.85% saline solution and rubbed over the 
analyzed areas. After collection, the part touching the swab shaft 
was broken on the inside of the tube edge, plunging the swab with 
material collected into saline 0.85%. This was homogenized and 
decimal dilutions proceeded. The diluent was then analyzed by 
0.1 mL aliquots plated on agar plates in EMB (Eosin Methylene 
Blue - Himedia, India) selective for E. coli. The EMB plates were 
incubated at 37 °C ± 2 °C / 24-48 h. The results were expressed as 
CFU/unit. The control surfaces without the use of antimicrobial 
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agents were also assessed.  
 
2.8. Statistical analysis  
 
For alginate-Ca matrix, a completely randomized design was 
adopted with three replications. The results were submitted to 
analysis of variance (ANOVA) with F test. When there was a 
significant difference in the F test at 5% probability, the Tukey test 
was applied. The results were evaluated using the Minitab 16® 
program.  
 
3. Results and discussion  
 
3.1. Dynamic light scattering (DLS)  
 
Dynamic light scattering was used to characterize the phage 
particles. The average diameter of the particles was 107 ± 1 nm (τ) 
that was calculated by the usual Stokes-Einstein equation from the 
diffusion coefficient obtained by the linear adjustment of a graph 
 ̅ versus q². This τ, called hydrodynamic diameter, is the diameter of 
the sphere with the same diffusion coefficient. This result was 
confirmed by transmission electronic microscopy (Figure 2), which 
showed the icosahedral head (114 by 86 nm) and contractile tail 
(117 by 23 nm) of the bacteriophage. These morphological 
parameters allowed the UFV-AREG1 phage to be included in the 
Caudovirales order and Myoviridae family [19].  
 
3.2. Microfluidic device and production of alginate-Ca 
microcapsules  
 
The size of the microcapsules was determined using the ImageJ 
program, and the scale used to calculate the size was 1.7513 
micrometers/pixel for the images. Initially, we opened the 
photograph corresponding to the desired flows; then we drew a 
square in which the drop should be circumscribed. The side of the 
square should have the same length as the diameter. We did this for 
several drops and obtained the mean value of the diameter and the 
standard deviation of the same. The average diameter of the 
alginate-Ca microcapsules ranged from 100 to 250 μm (Figure 3). 
By statistical data, the size of the alginate particles of Figure 3G was 
calculated, where about 40 particles were analyzed corresponding to 
a diameter of 251 μm with a standard deviation of 24.3% (Figure 4), 
showing that the system is not homogeneous.  
However, according to their size, the capsules are classified as 
nanoparticles or microparticles, ranging from (0.01 to 0.2) nm and (1 
 
 
 
 
Figure 2: Electron micrograph of phage UFV-AREG1. 
 
to 100) μm [23], and our microcapsules are in the order of 
micrometers and can be considered satisfactory for applications in 
antimicrobial gels, in which the microcapsules are added and 
homogenized in the solution in an unnoticeable visibility. As the gel 
is for cleaning the hands/surfaces, larger microcapsules can generate 
a sensation that would be unpleasant on the hands of manipulators, 
for example.  
Encapsulation using microfluidic devices allows the production 
of low polydisperse emulsions in this work, which are formed by a 
controlled flow. The device and the formation of the capsules can be 
observed in Figure 3 (A - G). By optical microscopy it was possible 
to observe the droplet formation coming out of constriction, with a 
circular shape and with homogeneous diameters in a flow of 50 
μL∙h–1 of the dispersed phase and 1000 μL∙h–1 of the continuous 
phase; however, by the end of the capillary to be collected droplets  
 
 
 
 
 
 
 
Figure 3: Microfluidic device and production of microcapsules with a flow 
rate of (50 μL∙h–1 - 200 μL∙h–1) and (1000 μL∙h–1 - 1500 μL∙h–1) for the 
dispersed and continuous phase, respectively. (A) device; (B) and (E) 
droplet formation in the constriction; (C) and (F) formed droplets alginate-
Na with phage before contact with the CaCl2 solution; and (D) and (G) 
alginate-Ca microcapsules containing the phage after contact with the 
CaCl2 solution. 
100 nm 
nm 
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have undergone coalescence and increased in size. This justifies the 
size variation when falling into the CaCl2 solution. Preliminary tests 
were performed to achieve the appropriate flow combination. In 
higher flow rates of the dispersed phase (200 μL∙h–1 and 1500 μL∙h–
1, respectively) there is the formation of larger microcapsules, as 
shown in Figure 3 (E-G). Variations in flow rates demonstrate that 
there can be difference in the average diameter of the droplets.  
The droplets of sodium alginate were collected in a 0.1 M 
solution of CaCl2 (Figure 1D), forming the calcium alginate 
microcapsules containing the microencapsulated bacteriophage. 
Once in contact with the chloride ions in solution, the capsules did 
not remain in a homogeneous size and, due to the impact of the fall, 
the capsules were misshapen (Figures 3D-G). The distance from the 
outlet capillary to the collection of drops in CaCl2 solution may have 
caused the deformation and the size difference of the microcapsule, 
because the drops in the capillary outlet pooled, and then fell into the 
chloride solution. These conditions may have occurred due to the 
lack of preparation in the use of the equipment.  
Hu and co-workers report in their work that several types of 
alginate microgels, such as hemi-spherical, mushroom-like, disk-
like, and red blood cell-like, among others, were prepared by 
adjusting the flow rate of the microfluidics and the gelation 
conditions. Besides flow rate, a unique external ionic crosslinking 
(gelation bath) was designed. The morphology of the microgel can 
be finely tuned continuously by simply varying the gelation 
conditions. A key advantage of this procedure for preparing 
microgels is that the morphology of the alginate microgels can be 
tuned continuously by simply changing height, as can the viscosity 
of the gelation bath by varying the content of glycerol and owing to 
the interplay between the viscous and elastic forces during the 
subsequent gelation process [24].  
Hu and co-workers employed simple capillary devices to 
evaluate the effect of flow rate and the impact on the formation of 
alginate-Na capsules, which formed nonspherical microcapsules 
after falling into the surfactant solution. This morphology is 
influenced by the contact speed, the droplet size and the 
concentration of the alginate solution. They concluded that 
depending on the concentration of the alginate solution, the droplets 
presented different rheological properties and, thus, showed different 
morphologies [25].  
C.-H. Yeh [26] using T junction microfluidic devices 
established flow rates of 0.05 mL∙min–1 and 0.5 mL∙min–1 for the 
dispersed and continuous phase, respectively, in the 
microencapsulation of nanoparticles in an alginate matrix, producing  
 
 
 
 
Figure 4: Size distribution for the alginate microcapsules of figure 3G. 
emulsions of 200 ± 10 μm diameter homogeneously distributed, and 
they verified that increasing sample flow rate (under fixed oil flow 
rate) contributes to an increase in the emulsion sizes, and that 
increasing oil flow rates leads to a decrease in the emulsion sizes. 
The work developed by Nisisako and contributors [27], also in a T 
junction device, produced droplets of 100 μm, increasing the flow 
rate of the continuous phase. Increasing the flow of the continuous 
phase the droplet size diminished. Changes in the flow rate also 
established the number of droplets produced by the device. 
Maintaining the dispersed phase flow constant and varying the 
continuous phase flow, a higher or lower production of droplets was 
obtained. These authors showed that the droplet production rate is a 
function of the flow of the continuous phase and, consequently, the 
production rate can be linearly increased.  
Huang and contributors [28] proposed an in situ method of 
alginate microcapsule production of controlled diameter, which can 
be an intelligent delivery system. The method resulted in two 
different diameters of alginate microcapsule produced and separated 
in microfluidic devices. The particles showed relative size 
homogeneity. They also noted that, in both particles, the size could 
be changed. Their results showed that the size droplets are 
equivalent to the channel diameter, and can be adjusted by varying 
the flow speed of the continuous phase in relation to the dispersed 
phase. Since the separation efficiency is high in this system, both 
droplet sizes are monodispersed and have elevated reproductivity. 
Ren and contributors [29] also developed a microfluidic device to 
produce monodispersed alginate microcapsules with double 
emulsion for the encapsulation of pharmaceuticals and active 
chemical products. The average capsule diameter was 117 and 255 
μm for the internal and external diameters, respectively. Our work 
showed that there was variation of the particle size when they were 
collected in the CaCl2 solution. The size can be influenced by the 
coalescence occurring at the end of the collection tube and the 
deformity by the height of the tube until the solution influenced by 
the rheological properties of the sample analyzed. The parameters 
and careful handling of the equipment need to be adjusted so that the 
formation of the alginate-Ca microcapsules maintains a low 
deformity and low size dispersion.  
 
3.3. Retention Efficiency (RE)  
 
The average initial concentration of the bacteriophage 
(expressed in PFU∙mL–1) added to the solution of sodium alginate-
Na 1.5% before injecting into the microfluidic device was 2.0 × 106 
PFU∙mL–1. The final concentration of the phage retained in the 
capsules was 1.4 × 105 PFU∙mL–1. Therefore, the retention 
efficiency using the microfluidic device to encapsulate the UFV-
AREG1 in the calcium alginate microcapsules was 82.1% ± 2%. 
Huang and co-workers proposed a device to microencapsulate 
chondrocyte cells, showing efficiency of 94 ± 2% viability of the 
cell after encapsulation. The device was capable of producing 
alginate microspheres or microencapsulating in a simple, 
continuous, controllable and homogeneous way, showing less 
contamination [30]. 
Liu and co-workers, using a microfluidic device to produce 
double emulsion of calcium alginate microcapsule, obtained a 
diameter of 323 μm and 227 μm for the external and internal 
emulsions, respectively. The same authors used bovine serum 
albumin protein as a model to encapsulate, and they obtained 
positive results for the encapsulation, determining that the 
methodology is viable for the encapsulation and to carry drugs and 
active chemical products [31].  
In another study using flow-focusing microfluidic devices to 
microencapsulate ascorbic acid in solid lipidic microcapsules to 
develop fortified foods, the retention efficiency in the lipidic matrix 
ranged from 74 to 96% per the initial composition on the matrix. 
 6 
 
The results showed a huge potential for microencapsulation to avoid 
ascorbic acid degradation in food products and, furthermore, can 
mask the acidic flavor of the compound [32].  
Biocontrol using bacteriophages is a promising method with 
advantages compared to other methods. The phage is self-limiting, 
that is, it replicates only in the presence of the bacterium to which it 
has affinity; it also does not act in the selection of resistant 
microorganisms, can be administered in a single dose, is easy to use, 
is safe for humans, plants and animals, and phages are ubiquitous 
and diverse. However, bacteriophages can recover the replication in 
conditions of temperature abuse, or even exhibit a passive activity 
that cause reductions without the need for the bacteriophage to 
replicate and complete their life cycle. The ratio of host cells and 
phages denominated as ―multiplicity of infection (MOI)‖ appears to 
be of great relevance to the successful application of this technology. 
Thus, it would be necessary to have lower concentrations than for 
other antimicrobial agents [33, 34].  
Bacteriophages fit into the classification of natural 
antimicrobials, and their effectiveness in controlling bacterial 
pathogens in the agro-food industry has led to the development of 
different phage products already approved by the Food and Drug 
Administration (FDA) and the United States Department of 
Agriculture (USDA) [35]. Phage encapsulation is a technique with 
the possibility of reducing viral death during passage through the 
gastrointestinal tract, as well as an alternative to control the release 
of these particles, and microfluidic devices have been shown to be 
efficient in the encapsulation of phages as well as other drugs, cells, 
food ingredients, etc.  
 
3.4. Confocal microscopy  
 
By the confocal microscopy technique, the bacteriophages were 
observed in the interior of microcapsules in a homogeneous way, 
due to the presence of isothiocyanate (FITC) used to mark the 
phages. The results are demonstrated in Figure 3.  
As shown in Figure 5, the labeling phage was present inside the 
microcapsules. These results show that the scanning confocal 
microscopy technique was efficient in demonstrating the presence of 
the phages. The retention efficiency test was also applied to the 
microcapsules with the labeled phage to confirm the results of 
microscopy. The marking methodology was proposed by Gitis 
 
 
 
 
Figure 5: Scanning confocal microscopy of the alginate-Ca microcapsules 
containing the bacteriophages labeled by fluorescence. 200X magnification 
and fluorescence at a 488 nm excitation. 
and co-workers [36] and reproduced by Bakhshayeshi and 
contributors [22]. In both works, the conclusion was that the 
bacteriophages were marked in free amino groups on the lysine 
amino acid residues of their capsid proteins, using FITC or another 
coloring agent. Thus, this technique has a wide range of viruses for 
application, including mammal viruses and bacteriophages, due to 
the presence of the lysine amino acid in the capsid of these groups, 
allowing viral particles with different dimensions, shapes and 
physicochemical properties to be studied [22].  
 
3.5. Stability of microcapsules in the propylene glycol gel and 
antimicrobial activity  
 
The microcapsule stability results are presented in Table 1. For 
21 days of storage at room temperature, the bacteriophages retained 
in the alginate microcapsules added to the gel remained viable, with 
no statistically different results from the control solution (alginate-
Na 1.5% before injecting into the microfluidic device added to 106 
PFU∙mL–1 solution of bacteriophages). This initial solution was used 
to produce the alginate-Ca microcapsules containing the 
bacteriophages and, after encapsulation, the capsules were added to 
the propylene glycol gel. The results demonstrate that the phages 
added in the alginate-Na solution were encapsulated in the alginate-
Ca microcapsules and remained stable for 21 days after the 
microcapsules were added to the propylene glycol gel. This 
demonstrates that alginate is a good polymer to be used in 
encapsulation processes of materials, not affecting the stability and 
viability of the encapsulated material.  
Furthermore, the alginate can be added to other polymer-based 
gels that are very stable, without affecting the structure of the 
alginate. The gel form presents as a stable suspension, being quite 
suitable for formulations of topical use. Gels are indicated for the 
delivery of water-soluble active substances and liposomes. They are 
most used in oily and mixed skins [37-39].  
Using the bacteriophages in the polymeric matrix of calcium 
alginate and agar-agar to immobilize phages specific for 
Pseudomonas aeruginosa, Balcão and co-workers [40] demonstrated 
the maintenance of lytic viability of the viral particles after 
immobilization in the biopolymeric matrix, confirmed by the 
presence of lysis plaques in the bacterial growth medium. The 
authors produced the gel without any encapsulation device. Tang 
and co-workers [41] used alginate microspheres coated with whey 
protein for preparation of a dry powder containing the K 
bacteriophage for oral administration to remain viable until the 
intestine. Their study showed that the encapsulated phage remained 
viable in simulated gastric fluid at pH 2.5 after 2 hours of 
incubation. The encapsulated phage was completely released in the 
simulated intestinal juice within 2 hours. They concluded that the 
microspheres could be a vehicle to transport the K bacteriophage by 
oral administration to control Staphylococcus aureus.  
The antimicrobial activity of the microencapsulated 
bacteriophages added to propylene glycol gel showed efficiency (not 
detectable on the surface) when applied to surfaces contaminated 
with E. coli O157:H7. The antimicrobial efficiency results were 
compared to an alcohol solution 70% applied to the same surface 
(not detectable in surface). Another surface without the application 
of any antimicrobial agents was used to compare the results. The 
bacterial growth on the surface without the application of 
antimicrobial agents was 4.92 log. It was observed that between the 
propylene glycol gel and the alcohol 70% there was no statistical 
difference in the antibacterial activity. Comparing with the control 
surface, the propylene glycol gel and the alcohol 70% were effective 
in sanitizing the surfaces. The initial inoculation of the surface was  
104 CFU∙mL–1.  
Using bacteriophages as antimicrobial agents in relation to other 
chemicals in the hygienization process of chicken skin 
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Table 1 Stability of the control alginate-Na before injecting into the 
microfluidic device added to the bacteriophage solution (A1) and of the 
alginate-Ca microcapsules containing the phages (A2) added to the propylene 
glycol gel during 21 days of storage at room temperature. 
 
Bacteriophage concentration (Log PFU∙mL-1) 
Samples 1 day 2 days 14 days 21 days 
A1 7.00 7.20 7.48 7.54 
A2 6.00 6.18 6.48 6.54 
 
 
contaminated with Salmonella sp., Hungaro et al. [42] observed that 
both bacteriophages and chemicals were efficient in reducing 
bacterial contamination. In this study, the phages were in solution 
and later sprayed over the chicken skin surface. Using cellulose 
acetate film incorporated with bacteriophages as an application in 
food packing, Gouvêa and co-workers [7] observed the antibacterial 
effect of the film containing the phages specific for Salmonella 
typhimurium in liquid medium and diffusion in solid medium, 
inhibiting bacterial growth. Bacteriophages incorporated in whey 
protein films applied in liquid medium and on food surfaces were 
released in the medium, causing antimicrobial effect after 6 h. The 
liberation was efficient both in liquid medium and on food surfaces 
[6].  
In our work, we can observe that the microencapsulated active 
principle (phage) remained stable during the 21 days of analysis of 
the gel; lytic activity of phage proved to be efficient after the 
application of the gel to the surface; and the microcapsules were 
ruptured via rubbing the gel, releasing phage to infect the bacterial 
cell. The bacteriophage, being an organic antimicrobial agent, shows 
different behavior from a chemical antimicrobial. As a virus, it needs 
the host to replicate, and therefore it must initially find the host in 
the environment, then infecting it and causing bacterial lysis (host 
death). Thus, the time of action of the bacteriophage is more 
dynamic. The chemical antimicrobial agent acts on the host 
immediately, eliminating it, but if there is a new infection, the 
antimicrobial chemical does not continue to act. In the case of 
bacteriophages, which are more dynamic, the process is better 
because it finds the host, infects it, replicates itself, causes lysis and 
releases new phage particles into the medium, restarting a new cycle. 
Within 24 h the multiplication process is still occurring because new 
virus particles are still being released to infect the host. Where the 
host is present, the bacteriophage is also able to restart a new cycle 
of replication and cell lysis.  
 
4. Conclusion  
 
The UFV-AREG1 bacteriophage was encapsulated in the 
calcium alginate matrix by the microfluidic technique using the 
capillary device with retention efficiency close to 90% of viral 
capsules in the capsules. The encapsulation was confirmed by 
confocal microscopy. Thereby, the capsules were applied in a 
propylene glycol gel, in which the bacteriophage remained viable for 
the 21 days of analysis. The antimicrobial gel application on 
contaminated surfaces was efficient to reduce bacterial 
contamination in relation to an antimicrobial chemical agent. Hence, 
it was possible to microencapsulate the phages in the alginate-Ca 
matrix and apply the capsules to antimicrobial gels to use as 
sanitizers in the food industry.  
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